CBZ

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 838.01 M683.5 M693.82 M542.66 M848.58 M682.21 M 2.77 B Gross profit 228.1 M87.91 M90.13 M-50.75 M226.02 M72.44 M 337.84 M Operating expenses 38.82 M23.71 M39.03 M41.77 M35.65 M38.37 M 154.81 M Selling/general/admin expenses 28.07 M27.64 M31.27 M34.41 M29.57 M38.37 M 133.61 M Research & development —————— — Operating income 200.03 M60.27 M58.86 M-85.16 M184.51 M34.07 M 192.28 M Non-Operating Income, Total -27.12 M-2.49 M-18.46 M-25.1 M30.02 M-10.39 M -23.92 M Interest expense, net of interest capitalized 25.16 M27.87 M27.96 M26.23 M23.92 M24.34 M 102.44 M Non-Operating Income, excl. Interest Expenses -25.16 M-27.87 M-26.84 M-26.64 M34.04 M-24.34 M -43.78 M Unusual income/expense -1.97 M25.37 M8.38 M1.54 M-4.02 M13.95 M 19.85 M Pretax income 172.91 M57.78 M40.41 M-110.26 M226.47 M23.69 M 180.3 M Equity in earnings —————— — Taxes 50.14 M15.84 M10.26 M-30.84 M64.86 M5.08 M 49.36 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 122.77 M41.94 M30.15 M-79.42 M161.61 M18.6 M 130.94 M Discontinued operations —————— — Net income 122.77 M41.94 M30.15 M-79.42 M161.61 M18.6 M 130.94 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 122.77 M41.94 M30.15 M-79.42 M161.61 M18.6 M 130.94 M Basic earnings per share (Basic EPS) 1.920.660.48-1.222.630.31 2.2 Diluted earnings per share (Diluted EPS) 1.910.660.48-1.222.630.31 2.2 Average basic shares outstanding 63.84 M63.54 M62.36 M62.91 M61.42 M59.5 M — Diluted shares outstanding 64.14 M63.78 M62.7 M63.24 M61.54 M59.7 M — EBITDA 214.07 M89.26 M75.56 M-68.56 M214.12 M59.14 M 280.25 M EBIT 189.28 M64.2 M51.1 M-92.52 M190.37 M34.07 M 183.02 M Cost of revenue 609.91 M595.59 M603.69 M593.41 M622.56 M609.77 M 2.43 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 24.79 M25.07 M24.45 M23.96 M23.75 M25.07 M —